Drawing for ELLISON INSTITUTE OF TECHNOLOGY

USPTO serial 98123216

ELLISON INSTITUTE OF TECHNOLOGY

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
MARSH, LAURA KATHLEEN
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 680 means the examining attorney approved your mark for publication in the USPTO Official Gazette. Publication for opposition usually follows within weeks, opening a 30-day window for third parties to oppose. Watch for publication (status 686) and monitor the 30-day opposition window.

Status 680: Status 680 means the examining attorney approved your mark for publication in the USPTO Official Gazette. Publication for opposition usually follows within weeks, opening a 30-day window for third parties to oppose.

Need help with ELLISON INSTITUTE OF TECHNOLOGY?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Aaron D. Hendelman

Aaron D. Hendelman WILSON SONSINI GOODRICH & ROSATI650 PAGE MILL ROADPALO ALTO, CA 94304-1050United States

Goods and services

ClassDescriptionStatusFirst use
035Compilation of statistics; arranging, conducting and hosting of exhibition, conferences and seminars for business purposes; collection and analysis of quality metric data in the fields of health, digital health, health data, healthcare access, disease prevention, medical and scientific research, health security, biomedical research, biotechnology, bioinformatics, bioengineering, data analytics, data science, food security, housing, and climate science for business purposesACTIVEOct 12, 2023
041Educational services, namely, providing courses of instruction at the high school, undergraduate and graduate level education in the fields of cancer prevention, cancer screening, cancer, diagnosis, cancer treatment, digital health, health data, healthcare access, disease prevention, education, medical and scientific research, health security, biomedical research, biotechnology, bioinformatics, bioengineering, data analytics, data science, food security, housing, and climate science; providing information in the fields of education via a website; providing a website featuring blogs and non-downloadable publications in the nature of articles in the fields of digital health, health data, healthcare access, disease prevention, education, medical and scientific research, health security, biomedical research, biotechnology, bioinformatics, bioengineering, data analytics, data science, food security, housing, and climate science; publication of educational and training guides; production of films for educational purposes; organization of educational competitions and awards to demonstrate excellence in the fields of digital health, disease prevention, education, medical and scientific research, health security, biomedical research, biotechnology, bioinformatics, bioengineering, data analytics, data science, food security, housing, and climate scienceACTIVEOct 12, 2023
042Development of biomedical technologies and products for others in the nature of biomedical education technologies; consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; research and development of vaccines and medicines; research, development, engineering and testing services in the fields of pharmaceuticals and vaccines; biotechnology research services, and research and development of new products in the fields of gene therapeutics; design of genetic research tools and systems for others; compiling data for research purposes in the fields of medical science; scientific research and development, namely, development of new scientific computational technologies to predict positive and negative regulators of gene network function; developing new technology for others in the field of computational genomics; genome sequencing services for scientific and research purposes; providing genetic sequencing and consulting services for clinical research purposes; vaccine research and development; application service provider, namely, hosting, managing, developing, analyzing, and maintaining applications, software, and web sites, of others in the fields of cancer treatment, cancer diagnosis, digital health, health data, healthcare access, disease prevention, education, medical and scientific research, health security, biomedical research, biotechnology, bioinformatics, bioengineering, data analytics, data science, food security, housing, and climate science; research in the field of artificial intelligence; providing temporary use of nondownloadable software using artificial intelligence for use in creating, developing, sharing and analyzing data in the fields of digital health, health data, healthcare access, disease prevention, education, medical and scientific research, health security, biomedical research, biotechnology, bioinformatics, bioengineering, data analytics, data science, food security, housing, and climate science; consulting services for others in the field of design, planning, and implementation project management of scientific research and clinical trials; genetic testing for medical research purposes; providing genetic sequencing and consulting services for medical research purposesACTIVEOct 12, 2023
044Healthcare services, namely, treatment and diagnosis of cancer; healthcare medical diagnostic testing, monitoring and reporting services for research purposes; health care services for treating cancerACTIVEOct 12, 2023

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 3, 2026CNTAAPPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER—
Nov 3, 2026IUAAUSE AMENDMENT ACCEPTED—
Oct 13, 2026AUPCAMENDMENT TO USE PROCESSING COMPLETE—
Oct 13, 2026IUAFUSE AMENDMENT FILED—
Oct 13, 2026EAAUTEAS AMENDMENT OF USE RECEIVED—
Oct 13, 2026ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Jun 24, 2026XELGAPPLICATION EXTENSION GRANTED/RECEIPT PROVIDED—
Jun 24, 2026XELRAPPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED—
Apr 13, 2026GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Apr 13, 2026GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Apr 13, 2026CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Dec 9, 2025TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Dec 9, 2025ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 9, 2025REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Aug 20, 2025DPCCDIVISIONAL PROCESSING COMPLETE—
Aug 20, 2025AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Aug 11, 2025IROARESPONSE TO ITU OFFICE ACTION ENTERED—
Aug 11, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 11, 2025INCDITU OFFICE ACTION ISSUED FOR DIVISIONAL REQUEST—
Aug 11, 2025AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
May 14, 2025ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Oct 9, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 9, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 9, 2024ALIEASSIGNED TO LIE—
Jun 21, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 21, 2024NREVNOTICE OF REVIVAL - E-MAILED—
Jun 21, 2024PETGPETITION TO REVIVE-GRANTED—
Jun 21, 2024PROATEAS PETITION TO REVIVE RECEIVED—
Jun 20, 2024DRRRDIVISIONAL REQUEST RECEIVED—
Jun 20, 2024ERTDTEAS REQUEST TO DIVIDE RECEIVED—
Mar 18, 2024XELGAPPLICATION EXTENSION GRANTED/RECEIPT PROVIDED—
Mar 18, 2024XELRAPPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED—
Dec 20, 2023GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 20, 2023GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 20, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 18, 2023DOCKASSIGNED TO EXAMINER—
Sep 7, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 11, 2023NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance